The pilot study on evaluation of EPA+DHA therapy with Endo-PAT
Not Applicable
- Conditions
- Cases with reduced vascular endothelial function
- Registration Number
- JPRN-UMIN000039168
- Lead Sponsor
- Shimane University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
Does not meet eligibility criteria
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in RHI value 12 weeks after starting EPA + DHA administration by Endo-PAT test
- Secondary Outcome Measures
Name Time Method